» Articles » PMID: 32954812

Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes

Overview
Specialty Endocrinology
Date 2020 Sep 21
PMID 32954812
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In this study, we evaluated the analytical performance of the second-generation factory-calibrated FreeStyle Libre Flash Glucose Monitoring (FreeStyle Libre 2) System compared to plasma venous blood glucose reference, Yellow Springs Instrument 2300 (YSI).

Methods: The study enrolled participants aged four and above with type 1 or type 2 diabetes at seven sites in the United States. Adult participants (18+ years) participated in three in-clinic sessions and pediatric participants (4-17 years) participated in up to two in-clinic sessions stratified to provide data for days 1, 2, 3, 7, 8, 9, 12, 13, or 14 of sensor wear. Participants aged 11+ underwent supervised glycemic manipulation during in-clinic sessions to achieve glucose levels across the measurement range of the System. Performance evaluation included accuracy measures such as the proportion of continuous glucose monitoring (CGM) values that were within ±20% or ±20 mg/dL of reference glucose values, and bias measures such as the mean absolute relative difference (MARD) between CGM and reference values.

Results: Data from the 144 adults and 129 pediatric participants were analyzed. Percent of sensor results within ±20%/20 mg/dL of YSI reference were 93.2% and 92.1%, and MARD was 9.2% and 9.7% for the adults and pediatric participants, respectively. The System performed well in the hypoglycemic range, with 94.3% of the results for the adult population and 96.1% of the data for pediatric population being within 15 mg/dL of the YSI reference. The time lag was 2.4 ± 4.6 minutes for adults and 2.1 ± 5.0 minutes for pediatrics.

Conclusions: The System demonstrated improved analytical accuracy performance across the dynamic range during the 14-day sensor wear period as compared to the previous-generation device.NCT#: NCT03607448 and NCT03820050.

Citing Articles

Feasibility of a Glucose Manipulation Procedure for the Standardized Performance Evaluation of Continuous Glucose Monitoring Systems.

Link M, Eichenlaub M, Waldenmaier D, Wehrstedt S, Pleus S, Jendrike N J Diabetes Sci Technol. 2025; :19322968251317526.

PMID: 39989334 PMC: 11848859. DOI: 10.1177/19322968251317526.


International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring.

Tauschman M, Cardona-Hernandez R, DeSalvo D, Hood K, Laptev D, Lindholm Olinder A Horm Res Paediatr. 2025; 97(6):615-635.

PMID: 39884260 PMC: 11854985. DOI: 10.1159/000543156.


Continuous Glucose Monitoring-New Diagnostic Tool in Complex Pathophysiological Disorder of Glucose Metabolism in Children and Adolescents with Obesity.

Simunovic M, Kumric M, Rusic D, Paradzik Simunovic M, Bozic J Diagnostics (Basel). 2025; 14(24.

PMID: 39767162 PMC: 11674695. DOI: 10.3390/diagnostics14242801.


Evaluating the precision and reliability of real-time continuous glucose monitoring systems in ambulatory settings: a systematic review.

Davila-Ruales V, Gilon L, Gomez A, Munoz O, Serrano M, Henao D Ther Adv Endocrinol Metab. 2024; 15:20420188241304459.

PMID: 39669532 PMC: 11635893. DOI: 10.1177/20420188241304459.


Continuous glucose monitoring in para cyclists: An observational study.

Weijer V, van der Werf R, van der Haijden M, Jeukendrup A, van Loon L, van Dijk J Eur J Sport Sci. 2024; 24(12):1809-1819.

PMID: 39587809 PMC: 11621371. DOI: 10.1002/ejsc.12220.


References
1.
Kudva Y, Ahmann A, Bergenstal R, Gavin 3rd J, Kruger D, Midyett L . Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults. J Endocr Soc. 2018; 2(12):1320-1337. PMC: 6243139. DOI: 10.1210/js.2018-00294. View

2.
Parkes J, Slatin S, Pardo S, Ginsberg B . A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000; 23(8):1143-8. DOI: 10.2337/diacare.23.8.1143. View

3.
Wadwa R, Laffel L, Shah V, Garg S . Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes. Diabetes Technol Ther. 2018; 20(6):395-402. PMC: 6110124. DOI: 10.1089/dia.2018.0150. View

4.
Bailey T, Bode B, Christiansen M, Klaff L, Alva S . The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technol Ther. 2015; 17(11):787-94. PMC: 4649725. DOI: 10.1089/dia.2014.0378. View

5.
Carlson A, Mullen D, Bergenstal R . Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes. Diabetes Technol Ther. 2017; 19(S2):S4-S11. PMC: 5444486. DOI: 10.1089/dia.2017.0024. View